InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
+6.6%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Smith Karen L., Vice-Président Exécutif et Directeur Médical. Officer active across 6 companies, notably Emergent BioSolutions Inc.. Aggregated, 14 reports have been logged. History available since 7 May 2021. The latest transaction was filed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
12,135 shares0Common SharesSEC:0001600620-24-000126:0
17,913 sharesCommon StockSEC:0001600620-24-000114:0
25,000 shares0Common StockSEC:0001415889-24-015762:0
13,900 shares0Common StockSEC:0001209191-23-034407:0
170,354 shares0Common StockSEC:0001209191-22-032677:0
54,193 shares@ US$5.6060.5% of flowCommon StockSEC:0000899243-22-019793:0
24,336 sharesCommon StockSEC:0001209191-22-031508:0
12,500 shares0Common StockSEC:0001209191-22-014157:0
1,622 sharesCommon StockSEC:0001104659-21-142277:0
1,622 sharesCommon StockSEC:0001104659-21-142277
25,452 shares@ US$4.4219.8% of flowCommon StockSEC:0001209191-21-040340
25,452 shares@ US$4.4219.8% of flowCommon StockSEC:0001209191-21-040340:0
305 shares@ US$60.850.0038% mcap50.0% of flowCommon StockSEC:0001367644-21-000081:0
305 shares@ US$60.8550.0% of flowCommon StockSEC:0001367644-21-000081
14 of 14 declarations
About Smith Karen L.
Karen L. Smith is EVP, Chief Medical Officer at Emergent BioSolutions Inc., Antares Pharma, Inc., and Acceleron Pharma Inc. She oversees medical and strategic initiatives, playing a key role in product development and innovation.
